Biosimilars
- Biosimilars: More Treatment Options Are on the Way
- FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US
Gout
- Alliance for Gout Awareness Resources
- Gout Patient Education & Resources
- PROTECT: Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label clinical trial
- RECIPE: Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
- MIRROR RCT: A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings
- Impact of Uncontrolled Gout on Quality of Life and Importance of Open Dialogue With Patients
- Pegloticase Prescribing Information
- Gout Patient fact Sheet
IgG4-Related Disease (IgG4-RD)
- 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease
- (ACR) Information on IgG4-Related Disease: What they are, Getting Diagnosed, Treatment Options, and More
- MITIGATE – Phase 3 Clinical Trial: Efficacy and Safety of Inebilizumab in IgG4-Related Disease
Psoriatic Arthritis
Spondyloarthritis
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
- JAK1 selective inhibitors for the treatment of spondyloarthropathies
- Recognizing Axial Spondyloarthritis: A Guide for Primary Care
- Spondylitis Association of America: Resources and Support
- Spondyloarthritis Patient Fact Sheet
- What Is Axial Spondyloarthritis (AxSpA)?
Juvenile Idiopathic Arthritis (JIA)
Lupus
- Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus
- Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial
- Lupus Foundation of America Caregiver Toolkit
- ACR Patient Fact Sheet: Lupus
- Belimumab prescribing information
- Voclosporin prescribing information
Rheumatoid Arthritis (RA)
- RA and Vaccinations
- The Purple Book for Biosimilars
- RA Overview (for Patients)
- RA Treatment (for Patients)
- FDA Information on Biosimilars (for Patients)
Systemic Sclerosis
Vasculitis
ANCA-Associated Vasculitis
- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- ANCA-Associated Vasculitis
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
- Vasculitis Foundation: Eosinophilic Granulomatosis With Polyangiitis
- NIH Genetic and Rare Diseases Information Center: Eosinophilic Granulomatosis With Polyangiitis
- National Organization for Rare Disorders: Churg Strauss Syndrome
